REC: Interventional Cardiology (English Ed.) (May 2020)

Impact of the COVID-19 pandemic on interventional cardiology activity in Spain

  • Oriol Rodríguez-Leor,
  • Belén Cid-Álvarez,
  • Soledad Ojeda,
  • Javier Martín-Moreiras,
  • José Ramón Rumoroso,
  • Ramón López-Palop,
  • Ana Serrador,
  • Ángel Cequier,
  • Rafael Romaguera,
  • Ignacio Cruz,
  • Armando Pérez de Prado,
  • Raúl Moreno

DOI
https://doi.org/10.24875/RECICE.M20000123
Journal volume & issue
Vol. 2, no. 2
pp. 82 – 89

Abstract

Read online

ABSTRACT Introduction and objectives: The COVID-19 epidemic and the declaration of the state of alarm have led to a decrease in healthcare activity in interventional cardiology units. The objective of this study is to quantify these changes in activity, with special interest in the treatment of patients with ST-segment elevation myocardial infarction (STEMI). Methods: A telematic survey of 81 centers involved in STEMI networks in the 17 autonomous communities of Spain. Information was collected on diagnostic activity, percutaneous coronary intervention (PCI), structural interventions, and PCI in STEMI on changes in the organization of STEMI networks, and on the prevalence of COVID-19 among interventional cardiologists. Data was compared for the week of February 24 through March 1 (before the outbreak) and for the week of March 16 through March 22 (during the outbreak). Results: Response has been obtained from 73 centers (90%). A very significant decrease in the number of diagnostic procedures (─56%), PCI (─48%), structural interventions (─81%) and PCI in STEMI (─40%) has been observed. A slight increase in the use of pharmacological thrombolysis has been reported, although primary angioplasty remains the leading reperfusion strategy. Up to 5% of interventional cardiologists (17) had COVID-19. Conclusions: An important reduction in the activity in interventional cardiology has been observed during the COVID-19 epidemic. Likewise, a great decrease has been detected in the number of patients treated in the STEMI networks, with the risk of increased morbidity and mortality that this represents. Scientific societies and health authorities have to promote that patients presenting STEMI compatible symptoms proceed with no delay to access the health system to receive reperfusion treatment in an appropriate way.

Keywords